Correction: Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients

There was an error in the title of this article. The correct title is: Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis Patients. The correct citation is: Weiner J 3rd, Parida SK, Maertzdorf J, Black GF, Repsilber D, et al. (2012) Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis Patients. PLoS ONE 7(7): e40221. doi:10.1371/journal.pone.0040221

[1]  Sirish L. Shah,et al.  Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. , 2009, Journal of proteome research.

[2]  Dirk Repsilber,et al.  Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.

[3]  K. Chida,et al.  Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis , 2012, Clinical and Vaccine Immunology.

[4]  J. van Staden,et al.  Plants used for stress-related ailments in traditional Zulu, Xhosa and Sotho medicine. Part 1: Plants used for headaches. , 1994, Journal of ethnopharmacology.

[5]  Qing Yang,et al.  Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  S. Gangal,et al.  Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. , 1990, The American review of respiratory disease.

[7]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[8]  G. Mills,et al.  Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.

[9]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[10]  B. Vickery,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2011, Pediatrics.

[11]  U. Grohmann,et al.  Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease , 2008, Nature.

[12]  Guowang Xu,et al.  A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Philippe Glaziou,et al.  Tuberculosis control and elimination 2010–50: cure, care, and social development , 2010, The Lancet.

[14]  Christian Baumgartner,et al.  Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. , 2008, The Journal of clinical investigation.

[15]  R. Wilkinson,et al.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.

[16]  U. Grohmann,et al.  Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.

[17]  E. Bateman,et al.  Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area , 2005, Thorax.

[18]  J. Ernst,et al.  Tuberculosis pathogenesis and immunity. , 2012, Annual review of pathology.

[19]  M. Avila,et al.  Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. , 1998, Gastroenterology.

[20]  C. MacKenzie,et al.  The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects , 2008, Journal of cellular and molecular medicine.

[21]  L. Boon,et al.  Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy , 2007, Nature Medicine.

[22]  J. Arm,et al.  Cytosolic Phospholipase A2 Participates with TNF-α in the Induction of Apoptosis of Human Macrophages Infected with Mycobacterium tuberculosis H37Ra1 , 2001, The Journal of Immunology.

[23]  Anne M. Evans,et al.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.

[24]  J. Nicholson,et al.  Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. , 2003, The Analyst.

[25]  杨军,et al.  Plasma Phospholipid Metabolic Profiling and Biomarkers of Type 2 Diabetes Mellitus Based on High Performance Liquid Chromatography/Electrospray Mass Spectrometry and Multivariate Statistical Analysis , 2005 .

[26]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[27]  Jeff E. Mold,et al.  Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.

[28]  M. Rudnicki,et al.  Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. , 2001, Kidney international. Supplement.

[29]  J. Utzinger,et al.  Global metabolic responses of mice to Trypanosoma brucei brucei infection , 2008, Proceedings of the National Academy of Sciences.

[30]  L. Allen Stem cells. , 2003, The New England journal of medicine.

[31]  M. Milburn,et al.  Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  P. Calder,et al.  Does glutamine contribute to immunosuppression after major burns? , 1990, The Lancet.

[33]  G. Prendergast,et al.  Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape , 2008, Immunological reviews.

[34]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[35]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[36]  J. Stypmann,et al.  Granulocyte colony–stimulating factor–induced blood stem cell mobilisation in patients with chronic heart failure , 2005, Basic Research in Cardiology.

[37]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[38]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[39]  B. Baban,et al.  Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. , 2010, Immunity.

[40]  Michael Platten,et al.  Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite , 2005, Science.

[41]  C. Unger,et al.  Lipids in Health and Disease Effects of 2 or 5 Consecutive Exercise Days on Adipocyte Area and Lipid Parameters in Wistar Rats , 2022 .

[42]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[43]  W. Chang,et al.  Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction , 1999, Clinical and experimental immunology.

[44]  Christopher D. Rithner,et al.  Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. , 2011, Journal of proteome research.

[45]  T. Y. Chan,et al.  Vitamin D Deficiency and Susceptibility to Tuberculosis , 2000, Calcified Tissue International.

[46]  J. Andrade,et al.  Biology and Clinical Uses , 2013 .

[47]  V. Hack,et al.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine , 1996, Journal of Molecular Medicine.

[48]  Sang-Nae Cho,et al.  NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis , 2011 .

[49]  A. Elfarra,et al.  In Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major Metabolites , 2006, Drug Metabolism and Disposition.

[50]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[51]  L. Romics,et al.  Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. , 2004, Atherosclerosis.

[52]  Trinad Chakraborty,et al.  Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. , 2006, The Journal of clinical investigation.

[53]  S. Wisniewski,et al.  Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. , 1998, Journal of neurotrauma.

[54]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[55]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.

[56]  Ignacio González,et al.  integrOmics: an R package to unravel relationships between two omics datasets , 2009, Bioinform..

[57]  D. Fuchs,et al.  HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. , 2007, Blood.

[58]  N. Enomoto,et al.  Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[59]  M. Sitkovsky,et al.  Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. , 2003, Blood.

[60]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[61]  K. Nishioka,et al.  Physiologic role of the complement system in host defense, disease, and malnutrition. , 1998, Nutrition.

[62]  M. Graeber Biomarkers for Parkinson's disease , 2009, Experimental Neurology.

[63]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[64]  W. Matson,et al.  Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.

[65]  R. K. Shepherd,et al.  Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.

[66]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[67]  Christian Gieger,et al.  A genome-wide association study of metabolic traits in human urine , 2011, Nature Genetics.

[68]  D. Munn,et al.  Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. , 2009, Blood.

[69]  Albert J. Fornace,et al.  Metabolomic Analysis in Severe Childhood Pneumonia in The Gambia, West Africa: Findings from a Pilot Study , 2010, PloS one.

[70]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[71]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[72]  A. Schwenk,et al.  Tuberculosis, malnutrition and wasting. , 2000, Current opinion in clinical nutrition and metabolic care.

[73]  B. Baban,et al.  Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. , 2011, The Journal of infectious diseases.

[74]  B. Baban,et al.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. , 2004, The Journal of clinical investigation.

[75]  R. Wilkinson,et al.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.